BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Microsoft
MSFT
|
+$962M |
| 2 |
Amazon
AMZN
|
+$682M |
| 3 |
Apple
AAPL
|
+$231M |
| 4 |
iShares MSCI Japan ETF
EWJ
|
+$200M |
| 5 |
Broadcom
AVGO
|
+$172M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.19B |
| 2 |
SPDR S&P Biotech ETF
XBI
|
+$457M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$421M |
| 4 |
Motorola Solutions
MSI
|
+$353M |
| 5 |
Industrial Select Sector SPDR Fund
XLI
|
+$323M |
Sector Composition
| 1 | Technology | 22.57% |
| 2 | Consumer Discretionary | 10.5% |
| 3 | Financials | 9.56% |
| 4 | Healthcare | 8.43% |
| 5 | Communication Services | 6.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Diana Shipping
DSX
$214M
| $50K | ﹤0.01% |
+16,111
| New | +$50K |
|
|
FUV
2952
DELISTED
Arcimoto, Inc. Common Stock
FUV
| $49.1K | ﹤0.01% |
316
+58
| +22% | +$9.02K |
|
|
SURF
2953
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $49K | ﹤0.01% |
10,247
+2,029
| +25% | +$9.7K |
|
2954
Rekor Systems
REKR
$140M
| $48.9K | ﹤0.01% |
7,465
+479
| +7% | +$3.14K |
|
2955
Smith Micro Software
SMSI
$15.3M
| $48.8K | ﹤0.01% |
1,241
-274
| -18% | -$10.8K |
|
|
STR
2956
DELISTED
Sitio Royalties
STR
| $48.8K | ﹤0.01% |
2,504
+455
| +22% | +$8.86K |
|
2957
Cemex
CX
$13.3B
| $48.5K | ﹤0.01% |
7,147
+1,136
| +19% | +$7.7K |
|
2958
Global X MSCI China Consumer Discretionary ETF
CHIQ
$244M
| $47.9K | ﹤0.01% |
+1,846
| New | +$47.9K |
|
|
GBL
2959
DELISTED
GAMCO Investors, Inc.
GBL
| $47.9K | ﹤0.01% |
1,917
+1,218
| +174% | +$30.4K |
|
2960
Shinhan Financial Group
SHG
$23.7B
| $47.9K | ﹤0.01% |
1,549
+584
| +61% | +$18.1K |
|
|
GSS
2961
DELISTED
Golden Star Resources Ltd.
GSS
| $47.9K | ﹤0.01% |
12,494
-6,217
| -33% | -$23.8K |
|
|
NAGE
2962
Niagen Bioscience, Inc. Common Stock
NAGE
$766M
| $47.8K | ﹤0.01% |
12,776
+4,005
| +46% | +$15K |
|
|
CMLS
2963
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $47.2K | ﹤0.01% |
4,198
+4,027
| +2,355% | +$45.3K |
|
2964
iBio
IBIO
$17.3M
| $47.1K | ﹤0.01% |
172
+50
| +41% | +$13.7K |
|
2965
iShares US Oil Equipment & Services ETF
IEZ
$115M
| $46.7K | ﹤0.01% |
+3,621
| New | +$46.7K |
|
|
QTNT
2966
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $46.4K | ﹤0.01% |
448
+83
| +23% | +$8.6K |
|
2967
Alaunos Therapeutics
TCRT
$4.83M
| $46.4K | ﹤0.01% |
284
+25
| +10% | +$4.08K |
|
2968
Mustang Bio
MBIO
$10.2M
| $45.9K | ﹤0.01% |
37
+16
| +76% | +$19.9K |
|
|
SIEN
2969
DELISTED
Sientra, Inc.
SIEN
| $45.4K | ﹤0.01% |
1,237
+217
| +21% | +$7.96K |
|
|
ALPN
2970
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $45K | ﹤0.01% |
3,246
+1,130
| +53% | +$15.7K |
|
2971
Evolus
EOLS
$475M
| $44.5K | ﹤0.01% |
6,832
+1,117
| +20% | +$7.27K |
|
2972
Pulse Biosciences
PLSE
$994M
| $44.4K | ﹤0.01% |
2,998
-103
| -3% | -$1.53K |
|
2973
Applied Therapeutics
APLT
$64M
| $43.4K | ﹤0.01% |
4,850
+1,715
| +55% | +$15.3K |
|
2974
ArcelorMittal
MT
$26.2B
| $43.1K | ﹤0.01% |
1,353
+611
| +82% | +$19.4K |
|
2975
Nathan's Famous
NATH
$437M
| $42.9K | ﹤0.01% |
734
+174
| +31% | +$10.2K |
|